Skip to main content

Advertisement

Figure 3 | Annals of General Psychiatry

Figure 3

From: Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies

Figure 3

Frequency of different types of relapse during double-blind phase (entire exposure period). Categories are not mutually exclusive; some subjects met >1 relapse criterion. Asterisk indicates increase for two consecutive assessments in pre-specified individual PANSS item scores to ≥5 for subjects whose score was ≤3 at randomisation. ER extended release, PANSS Positive and Negative Syndrome Scale, PP paliperidone palmitate.

Back to article page